Raymond Goodrich

Raymond Goodrich

UNVERIFIED PROFILE

Are you Raymond Goodrich?   Register this Author

Register author
Raymond Goodrich

Raymond Goodrich

Publications by authors named "Raymond Goodrich"

Are you Raymond Goodrich?   Register this Author

73Publications

1327Reads

23Profile Views

Improved in vitro quality of stored red blood cells upon oxygen reduction prior to riboflavin/UV light treatment of whole blood.

Transfusion 2019 Oct 13;59(10):3197-3204. Epub 2019 Aug 13.

Centre for Innovation, Canadian Blood Services, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.15485DOI Listing
October 2019

Reflections on the dynamics of bacterial and viral contamination of blood components and the levels of efficacy for pathogen inactivation processes.

Transfus Apher Sci 2018 Oct 11;57(5):683-688. Epub 2018 Sep 11.

Colorado State University, Fort Collins, CO, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.transci.2018.09.004DOI Listing
October 2018

Special considerations for the use of pathogen reduced blood components in pediatric patients: An overview.

Transfus Apher Sci 2018 Jun 16;57(3):374-377. Epub 2018 May 16.

International Consultancy in Blood Components Quality/Safety improvement, Audit/Inspection, and DDR Strategies, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.transci.2018.05.022DOI Listing
June 2018

Ignorance is not bliss.

Transfusion 2018 03;58(3):615-616

Infectious Disease Research Center, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.14486DOI Listing
March 2018

Characterization of posttransfusion Plasmodium falciparum infection in semi-immune nonparasitemic patients.

Transfusion 2016 09 24;56(9):2374-83. Epub 2016 Jun 24.

Transfusion Medicine Unit, Komfo Anokye Teaching Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.13706DOI Listing
September 2016

Protein translation occurs in platelet concentrates despite riboflavin/UV light pathogen inactivation treatment.

Proteomics Clin Appl 2016 08 21;10(8):839-50. Epub 2016 Jun 21.

Centre for Innovation, Canadian Blood Services, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/prca.201500139DOI Listing
August 2016

Chemical and biological mechanisms of pathogen reduction technologies.

Photochem Photobiol 2014 Sep-Oct;90(5):957-64. Epub 2014 Aug 20.

Terumo BCT, Lakewood, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/php.12311DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277684PMC
September 2015

Treatment of Whole Blood With Riboflavin and UV Light: Impact on Malaria Parasite Viability and Whole Blood Storage.

Shock 2015 Aug;44 Suppl 1:33-8

*Transfusion Medicine Unit and †Department of Clinical Microbiology, Kwame Nkrumah University of Science and Technology/Komfo Anokye Teaching Hospital, Kumasi, Ghana; ‡Dept of Haematology, University of Cambridge, Cambridge, UK; and §Colorado State University, Ft Collins; and ∥Terumo BCT, Lakewood, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SHK.0000000000000280DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498649PMC
August 2015

The effect of riboflavin and ultraviolet light on the infectivity of arboviruses.

Transfusion 2015 Apr 5;55(4):824-31. Epub 2014 Nov 5.

Research and Development, Australian Red Cross Blood Service, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.12899DOI Listing
April 2015

Large animal evaluation of riboflavin and ultraviolet light-treated whole blood transfusion in a diffuse, nonsurgical bleeding porcine model.

Transfusion 2015 Mar 13;55(3):532-43. Epub 2015 Jan 13.

Division of Trauma Surgery and Surgical Critical Care, Department of Surgery, Keck School of Medicine of University of Southern California, Los Angeles, California.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/trf.12894
Publisher Site
http://dx.doi.org/10.1111/trf.12894DOI Listing
March 2015

Reduction of Leishmania donovani infectivity in whole blood using riboflavin and ultraviolet light.

Transfusion 2015 Feb 25;55(2):326-9. Epub 2014 Aug 25.

Transmissible Diseases Department, American Red Cross Holland Laboratory, Rockville, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.12820DOI Listing
February 2015

Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment.

Transfusion 2013 Dec 22;53(12):3164-73. Epub 2013 Mar 22.

Canadian Blood Services, Vancouver, BC, Canada; Centre for Blood Research, University of British Columbia, Vancouver, BC, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada; Terumo BCT Biotechnologies, Lakewood, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.12173DOI Listing
December 2013

Plasma constituent integrity in pre-storage vs. post-storage riboflavin and UV-light treatment--a comparative study.

Transfus Apher Sci 2013 Dec 29;49(3):434-9. Epub 2013 Jun 29.

Institute for Medical Research, University of Belgrade, Serbia; Institute for Transfusiology and Hemobiology of MMA, Belgrade, Serbia; Faculty of Medicine of MMA, University of Defense, Serbia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.transci.2013.05.035DOI Listing
December 2013

Immune modulation and lack of alloimmunization following transfusion with pathogen-reduced platelets in mice.

Transfusion 2013 Nov 3;53(11):2697-709. Epub 2013 Mar 3.

Blood Systems Research Institute, San Francisco, California; Department of Laboratory Medicine, University of California, San Francisco, California; Terumo BCT Biotechnologies, Lakewood, Colorado; Department of Medicine, University of California, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.12133DOI Listing
November 2013

Inactivation of Plasmodium spp. in plasma and platelet concentrates using riboflavin and ultraviolet light.

Transfusion 2013 Oct 16;53(10):2278-86. Epub 2013 Jan 16.

Terumo BCT, LLC, Lakewood, Colorado; Colorado State University, Fort Collins, Colorado; Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia; Atlanta Research and Education Foundation, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/trf.12079
Publisher Site
http://dx.doi.org/10.1111/trf.12079DOI Listing
October 2013

A pilot study to assess the hemostatic function of pathogen-reduced platelets in patients with thrombocytopenia.

Transfusion 2013 Sep 24;53(9):2043-52. Epub 2012 Dec 24.

Department of Clinical Immunology, Section of Transfusion Medicine, Copenhagen, Denmark; Department of Hematology, University of Copenhagen, Copenhagen, Denmark; Terumo BCT, Lakewood, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.12055DOI Listing
September 2013

Riboflavin and ultraviolet light reduce the infectivity of Babesia microti in whole blood.

Transfusion 2013 Apr 13;53(4):860-7. Epub 2012 Jul 13.

Transmissible Diseases Department, American Red Cross Holland Laboratory, Rockville, MD 20855, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1537-2995.2012.03791.xDOI Listing
April 2013

Photochemical inactivation of chikungunya virus in plasma and platelets using the Mirasol pathogen reduction technology system.

Transfusion 2013 Feb 25;53(2):284-90. Epub 2012 May 25.

Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1537-2995.2012.03717.xDOI Listing
February 2013

Development of a riboflavin and ultraviolet light-based device to treat whole blood.

Transfusion 2013 Jan;53 Suppl 1:131S-136S

Terumo BCT Biotechnologies, LLC, Lakewood, Colorado, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.12047DOI Listing
January 2013

In reply to: "Is the SCID mouse model applicable to human acute lung injury?".

Transfusion 2012 Nov;52(11):2489-92; author reply 2492-4

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1537-2995.2012.03852.xDOI Listing
November 2012

Fresh whole blood use for hemorrhagic shock: preserving benefit while avoiding complications.

Anesth Analg 2012 Oct 4;115(4):751-8. Epub 2012 Jul 4.

Department of Pediatrics, Washington University in St. Louis, St. Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/anesthesia-analgesia/2012/10000
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1213/ANE.0b013e318261f40eDOI Listing
October 2012

Preparation of cryoprecipitate from riboflavin and UV light-treated plasma.

Transfus Apher Sci 2012 Apr 17;46(2):153-8. Epub 2012 Feb 17.

CaridianBCT Biotechnologies, LLC, Lakewood, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.transci.2012.01.004DOI Listing
April 2012

Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole blood.

Transfusion 2012 Feb 9;52(2):409-16. Epub 2011 Aug 9.

Transmissible Diseases Department, Jerome H. Holland Laboratory, American Red Cross, Rockville, Maryland 20855, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1537-2995.2011.03285.xDOI Listing
February 2012

Quality of proteins in riboflavin and UV light-treated FFP during 1 year of storage at -18°C.

Transfus Apher Sci 2012 Feb 23;46(1):15-8. Epub 2011 Nov 23.

CaridianBCT Biotechnologies, LLC, Lakewood, CO 80215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.transci.2011.10.015DOI Listing
February 2012

Improving blood safety and patient outcomes with pathogen reduction technology.

Transfus Apher Sci 2011 Dec 9;45(3):229-38. Epub 2011 Nov 9.

CardianBCT Biotechnologies, LLC, Lakewood, CO 80215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.transci.2011.10.001DOI Listing
December 2011

Generation of neutrophil priming activity by cell-containing blood components treated with pathogen reduction technology and stored in platelet additive solutions.

Transfusion 2011 Jun 13;51(6):1220-7. Epub 2010 Dec 13.

Bonfils Blood Center and the Center for Cancer and Blood Disorders, The Children's Hospital, Denver, Colorado, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1537-2995.2010.02983.xDOI Listing
June 2011

Impact of pathogen reduction technology and storage in platelet additive solutions on platelet function.

Transfusion 2011 Apr 26;51(4):808-15. Epub 2010 Oct 26.

Servicio de Hemoterapia y Hemostasia, Hospital Clínic, C/ Villarroel 170, Barcelona 08036, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1537-2995.2010.02914.xDOI Listing
April 2011

Hemostatic function of buffy coat platelets in additive solution treated with pathogen reduction technology.

Transfusion 2011 Feb 16;51(2):344-56. Epub 2010 Aug 16.

Section for Transfusion Medicine, Capital Region Blood Bank, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1537-2995.2010.02821.xDOI Listing
February 2011

Protein stability of previously frozen plasma, riboflavin and UV light-treated, refrozen and stored for up to 2 years at -30 °C.

Transfus Apher Sci 2011 Feb 19;44(1):25-31. Epub 2011 Jan 19.

CaridianBCT Biotechnologies, LLC, Lakewood, CO 80215, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.transci.2010.12.005DOI Listing
February 2011

Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light.

Transfus Med Hemother 2011 31;38(1):8-18. Epub 2011 Jan 31.

CaridianBCT Biotechnologies, Lakewood, CO, USA.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/324160
Publisher Site
http://dx.doi.org/10.1159/000324160DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132976PMC
January 2011

In vitro cell quality of buffy coat platelets in additive solution treated with pathogen reduction technology.

Transfusion 2010 Oct 4;50(10):2210-9. Epub 2010 Oct 4.

Section for Transfusion Medicine, Capital Region Blood Bank, Department of Clinical Immunology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1537-2995.2010.02681.xDOI Listing
October 2010

Defining "adequate" pathogen reduction performance for transfused blood components.

Transfusion 2010 Aug;50(8):1827-37

CaridianBCT Biotechnologies, LLC, Lakewood, Colorado 80215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1537-2995.2010.02635.xDOI Listing
August 2010

Evaluation of the Mirasol pathogen [corrected] reduction technology system against Babesia microti in apheresis platelets and plasma.

Transfusion 2010 May 18;50(5):1019-27. Epub 2009 Dec 18.

Transmissible Diseases Department, Jerome H. Holland Laboratory, American Red Cross, Rockville, Maryland 20855, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1537-2995.2009.02538.xDOI Listing
May 2010

Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products.

Biologicals 2010 Jan 25;38(1):20-30. Epub 2010 Jan 25.

CaridianBCT Biotechnologies LLC, 1215 Quail Street, Lakewood, CO 80215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biologicals.2009.10.016DOI Listing
January 2010

Understanding loss of donor white blood cell immunogenicity after pathogen reduction: mechanisms of action in ultraviolet illumination and riboflavin treatment.

Transfusion 2009 Dec 4;49(12):2686-99. Epub 2009 Aug 4.

Department of Laboratory Medicine and Medicine, Blood Systems Research Institute, University of California, San Francisco, California, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1537-2995.2009.02333.x
Publisher Site
http://dx.doi.org/10.1111/j.1537-2995.2009.02333.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865145PMC
December 2009

A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns.

Transfusion 2009 Jun 20;49(6):1205-16. Epub 2009 Mar 20.

CaridianBCT Biotechnologies LLC, Lakewood, CO 80215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1537-2995.2009.02126.xDOI Listing
June 2009

Reduction of prion infectivity in packed red blood cells.

Biochem Biophys Res Commun 2008 Dec 11;377(2):373-378. Epub 2008 Oct 11.

Department of Neurology, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2008.09.141DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2606671PMC
December 2008

Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light.

Transfus Apher Sci 2007 Oct 22;37(2):131-7. Epub 2007 Oct 22.

Walter Reed Army Institute of Research, Department of Blood Research, Transfusion Medicine Branch, Silver Spring, MD 20910-7500, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.transci.2007.07.002DOI Listing
October 2007

Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice.

Transfusion 2006 Sep;46(9):1553-60

Department of Medicine, Rhode Island Hospital/Brown University, Providence, Rhode Island 02903, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1537-2995.2006.00939.xDOI Listing
September 2006

The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends.

Transfus Apher Sci 2006 Aug 28;35(1):5-17. Epub 2006 Aug 28.

Navigant Biotechnologies Inc, Lakewood, CO 80215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.transci.2006.01.007DOI Listing
August 2006

Functional inactivation of white blood cells by Mirasol treatment.

Transfusion 2006 Apr;46(4):642-8

Department of Medicine, Rhode Island Hospital/ Brown University, Providence, 02903, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1537-2995.2006.00777.xDOI Listing
April 2006

An action spectrum of the riboflavin-photosensitized inactivation of Lambda phage.

Photochem Photobiol 2005 Mar-Apr;81(2):474-80

Department of Chemistry, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1562/2004-08-25-RA-292DOI Listing
September 2005

Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology.

Transfusion 2005 Jun;45(6):920-6

Navigant Biotechnologies, Inc., Lakewood, Colorado 80215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1537-2995.2005.04381.xDOI Listing
June 2005